HFA
TWST icon

Hoover Financial Advisors’s Twist Bioscience TWST Stock Holding History

Hoover Financial Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,125
Closed -$51K – 454
2020
Q2 		$51K Buy
+1,125
New +$40.4K 0.02% 190

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hoover Financial Advisors's TWST Position: Q3 2020 in Review

Hoover Financial Advisors sold out of Twist Bioscience (TWST) in Q3 2020, closing a stake of 1,125 shares — an estimated $51K sold.

Hoover Financial Advisors first reported a position in TWST in Q2 2020 and held it in 1 quarter. The position peaked at $51K in Q2 2020. 193 funds tracked by Wall St. Rank hold TWST as of Q3 2020.

  • Hoover Financial Advisors reported no remaining Twist Bioscience position as of Q3 2020 after selling out during the quarter.
  • Hoover Financial Advisors sold 1,125 Twist Bioscience shares in Q3 2020, an estimated $51K.
  • Hoover Financial Advisors first reported a position in Twist Bioscience in Q2 2020 and held it in 1 quarter.
  • Hoover Financial Advisors's Twist Bioscience position peaked at $51K in Q2 2020.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2020.

Based on Hoover Financial Advisors's 13F filing for Q3 2020, filed 21 Oct 2020.